FY7-33850-33553
3 vaccinations
3 coded responses
14 check-ins
3 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 46-50
- ZIP prefix
- 278 / NC
- Registered
- 2021-03-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-19
Dose 1 — Pfizer-BioNTech
-
2021-03-27
Registered in v-safe
- 2021-03-27
-
2021-04-02
Survey response — day 14, dose 1MedDRA: Headache, Myalgia, Nausea, Pyrexia — Feeling: FairFree text: Within 48 hours of vaccination, I experienced a slight fever, mild headaches, mild muscular aches, slight nausea.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-09
Survey response — day 21, dose 1MedDRA: Arthralgia, Back pain, Hypoaesthesia, Myalgia — Feeling: FairFree text: Upper back muscle soreness, shoulder muscle soreness & numbnessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-16
Dose 2 — Pfizer-BioNTech
- 2021-04-23
- 2021-05-02
- 2021-05-07
- 2021-05-14
- 2021-05-21
- 2021-05-28
- 2021-07-16
- 2021-10-15
-
2021-12-15
Dose 3 — Pfizer-BioNTech
-
2022-04-16
Survey response — 12 months, dose 2MedDRA: Allergic respiratory symptom, Cough, Lacrimation increased, Respiratory symptom, Rhinorrhoea, Sneezing — Feeling: GoodFree text: Intense upper respiratory symptoms of VERY short duration (sneezing, constant runny nose, watery eyes, followed by dry coughing). These symptoms only lasted approximately 24/36 hours. Symptoms were similar to seasonal allergies of some individuals.MedDRA releases: 2024-11 · check-in free text available
- 2022-06-15
- 2022-12-15
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-19 | Pfizer-BioNTech | |
| 2 | 2021-04-16 | Pfizer-BioNTech | |
| 3 | 2021-12-15 | Pfizer-BioNTech | No |
Free text
Release 6 — day 14, dose 1
Symptoms: Within 48 hours of vaccination, I experienced a slight fever, mild headaches, mild muscular aches, slight nausea.
Release 7 — day 21, dose 1
Symptoms: Upper back muscle soreness, shoulder muscle soreness & numbness
Release 11 — 12 months, dose 2
Symptoms: Intense upper respiratory symptoms of VERY short duration (sneezing, constant runny nose, watery eyes, followed by dry coughing). These symptoms only lasted approximately 24/36 hours. Symptoms were similar to seasonal allergies of some individuals. cut off by CDC
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Allergic respiratory symptom | · | · | ✓ |
| SD | Arthralgia | ✓ | ✓ | ✓ |
| SD | Back pain | ✓ | ✓ | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Hypoaesthesia | ✓ | ✓ | ✓ |
| SD | Lacrimation increased | · | · | ✓ |
| SD | Myalgia | ✓ | ✓ | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Pyrexia | ✓ | ✓ | ✓ |
| SD | Respiratory symptom | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release